3D QSAR studies on T-type calcium channel blockers using CoMFA and CoMSIA

Bioorganic and Medicinal Chemistry

Volumn 12, Issue 7, 2004, Pages 1613-1621

  Doddareddy, Munikumar Reddy ^a   Jung, Hee Kyung ^a   Cha, Joo Hwan ^a   Cho, Yong Seo ^a   Koh, Hun Yeong ^a   Chang, Moon Ho ^a   Pae, Ae Nim ^a  

^a Korea Institute of Science and Technology   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL T TYPE; ISOXAZOLE DERIVATIVE; LIGAND;

ARTICLE; CATALYST; COMPARATIVE MOLECULAR FIELD ANALYSIS; COMPARATIVE MOLECULAR SIMILARITY INDICES ANALYSIS; EMBRYO; HUMAN; HUMAN CELL; IC 50; MATHEMATICAL COMPUTING; MODEL; PHARMACOPHORE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, T-TYPE; DRUG DESIGN; MODELS, CHEMICAL; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PREDICTIVE VALUE OF TESTS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; REPRODUCIBILITY OF RESULTS;

EID: 1542613311     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2004.01.028     Document Type: Article

References (30)

1. Opie, L. H.; Frishman, W. H.; Thadani, U. Calcium channel antagonists (calcium entry blockers). In: Opie L. H., (Ed.) Drugs for the Heart. 4th ed. Philadelphia: WB Saunders; 1999, 50-82.
2. Abernethy D.R., Schwartz J.B. N. Engl. J. Med. 341:1999;1447.
3. Thadani U. Curr. Opin. Cardiol. 14:1999;349.
4. Asirvatham S., Sebastian C., Thadani U. Drug Safety. 19:1998;23.
5. Triggle D.J. J. Hypertens. 15(5 Suppl):1997;9.
6. Portegies M.C., Schmitt R., Kraaij C.J., Braat S.H.J.G., Gassner A., Hagemeijer F., Ponzenel H., Prager G., Viersma J.W., VanderWall E.E., Kleinbloesem C.H., Lie K.I. J. Cardiovasc. Pharmacol. 18:1991;746.
7. Cremers B., Flesch M., Sudkamp M., Bohm M. J. Cardiovasc. Pharmacol. 29:1997;692.
8. Ertel S.I., Ertel E.A., Clozel J.P. Cardiovasc. Drugs Ther. 11:1997;723.
9. Mishra S.K., Hermsmeyer K. Circ. Res. 75:1994;144.
10. Benardeau, A.; Ertel, E. Selective block of myocardial T-type calcium channels by mibefradil: A comparison with the 1,4-dihydropyridine,amlodipine, Edited by Clozel, J. P., Nargeot, J., Tsien, R. W., 1997, p 386, Adis international chester,UK.
11. Kobrin I., Bieska G., Charlon V., Lindberg E., Pordy R. Cardiology. 89:1998;23.
12. Schmassmann-Suhijar D., Bullingham R., Gasser R., Schmutz J., Haefeli W.E. Lancet. 351:1998;1929.
13. Mullins M.E., Horowitz B.Z., Linden D.H., Smith G.W., Norton R.L., Stump J. JAMA. 280:1998;157.
14. SoRelle R. Circulation. 98:1998;831.
15. Reimer, K. A., Califf, R. M. Circulation 1999, 99, 198
16. Bioorg. Med. Chem. Lett., submitted for publication.
17. Crammer R.D. III, Patterson D.E., Bunce J.D. J. Am. Chem. Soc. 110:1988;5959.
18. Klebe G., Abraham U., Mietzner T. J. Med. Chem. 37:1994;4130. 102, 1239.
19. Klebe G., Abraham U. J. Comput.-Aided Mol. Design. 13:1999;1.
20. Bohm M., Sturzebecher J., Klebe G. J. Med. Chem. 42:1999;458.
21. SYBYL 6.9. Tripos Inc., 1699 Hanley Road, St. Louis, MO 63144.
22. Clark M., Cramer R.D. III, Van Opdenbosch N. J. Comput. Chem. 10:1989;982.
23. CATALYST version 4.8 software; ACCELRYS Inc:2001.
24. Bioorg. Med. Chem., accepted for publication.
25. Viswanadhan V.N., Ghose A.K., Revenkar G.R., Robins R. J. Chem. Inf. Comput. Sci. 29:1989;163.
26. Klebe G. J. Mol. Biol. 237:1994;212.
27. Wold, S.; Albano, C.; Dunn, W. J.; Edlund, U.; Esbenson,K.; Geladi, P.; Hellberg, S.; Lindburg, W.; Sjostrom, M. In Chemometrics; Kowalski. B., Int. Ed.; Reidel: Dordrecht, The Netherlands, 1984, 17.
28. Geladi P. J. Chemon. 2:1998;231.
29. Cramer R.D. III, Bunce J.D., Patterson D.E. Quant. Struct. Act. Relat. 7:1988;18.
30. Wold S. Technometrics. 4:1978;397.